Biotech Analyst Goonewardene holds a conference call with management.on November 3 at 3 pm hosted by Truist.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACLX:
- Arcellx price target raised to $130 from $121 at Canaccord
- Arcellx management to meet with Piper Sandler
- Arcellx’s iMMagine-3 Study: A Potential Game-Changer for Multiple Myeloma Treatment
- Arcellx Advances in Autoimmune Treatment with Anitocabtagene Autoleucel Study
- Arcellx resumed with a Buy at Stifel